Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 622 | -9,516 | -7,850 | -4,445 | -6,880 |
| Depreciation Amortization | 1,791 | 7,855 | 5,824 | 3,818 | 1,918 |
| Income taxes - deferred | -55 | -414 | -160 | 1,040 | -123 |
| Accounts receivable | -923 | 4,780 | 6,060 | 3,587 | 1,506 |
| Accounts payable and accrued liabilities | -150 | -1,399 | -2,379 | -435 | 2,729 |
| Other Working Capital | -1,296 | 2,716 | 1,158 | -951 | 2,076 |
| Other Operating Activity | 1,823 | -2,870 | -4,180 | -4,790 | -3,212 |
| Operating Cash Flow | $1,812 | $1,152 | $-1,527 | $-2,176 | $-1,986 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 288 | -1,590 | -1,355 | -913 | -471 |
| Investing Cash Flow | $288 | $-1,590 | $-1,355 | $-913 | $-471 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,500 | 7,800 | 7,800 | 5,300 | 1,500 |
| Debt Repayment | -4,341 | -9,586 | -7,086 | -5,286 | -936 |
| Common Stock Issued | 104 | 577 | 346 | 282 | 31 |
| Other Financing Activity | -156 | -1,628 | -1,167 | -780 | -501 |
| Financing Cash Flow | $-2,893 | $-2,837 | $-107 | $-484 | $94 |
| Exchange Rate Effect | 74 | -38 | 312 | 11 | -25 |
| Beginning Cash Position | 4,508 | 7,821 | 7,821 | 7,821 | 7,821 |
| End Cash Position | 3,789 | 4,508 | 5,144 | 4,259 | 5,433 |
| Net Cash Flow | $-719 | $-3,313 | $-2,677 | $-3,562 | $-2,388 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,812 | 1,152 | -1,527 | -2,176 | -1,986 |
| Capital Expenditure | -224 | -1,590 | -1,355 | -913 | -471 |
| Free Cash Flow | 1,588 | -438 | -2,882 | -3,089 | -2,457 |